Table 1 Study characteristics
Programme | Evaluation methods used | Countries |
|---|---|---|
Semi-structured interviews with key informants (national, regional, district and facility levels) | Bangladesh, Brazil, Cameroon, Ethiopia, Tajikistan, Viet Nam | |
Reviews of secondary documents | ||
New vaccine introduction | Semi-structured interviews with key informants (national, regional and district levels) | Cameroon Ethiopia Guatemala Kenya Rwanda, Mali |
PCV | Questionnaire with health facility staff | |
Rotavirus | Routine health service use data | |
HPV | ||
Meningitis A[11] | ||
Polio eradication[12] | Semi-structured interviews with key informants (national, district and community levels) | Nepal, India, Pakistan, Nigeria, Ethiopia, Rwanda, Angola |
Participant observation in polio campaigns, surveillance, and routine health post activities | ||
Reviews of documents | ||
Routine health service use data | ||
DPT3 coverage data from DHS and IHME | ||
Attended births and antenatal care coverage data from DHS |